CHTP Key Stats
- Chelsea Therapeutics Reports First Quarter 2013 Financial Results noodls May 1
- Chelsea Therapeutics International Ltd. (CHTP) Posts Q1 Loss of 6c/Share Street Insider May 1
- CHELSEA THERAPEUTICS INTERNATIONAL, LTD. Files SEC form 10-Q, Quarterly Report May 1
- Chelsea Therapeutics to Present at the 12th Annual Needham Healthcare Conference noodls Apr 24
- Lead Counsel in Securities Class Action Against Chelsea Therapeutics Internation... Apr 19
- CHELSEA THERAPEUTICS INTERNATIONAL, LTD. Files SEC form 8-K, Change in Directors... Apr 19
- Is Chelsea Therapeutics A Buy After Skyrocketing Up Over 150%? Apr 8
- Why Starbucks is a Screaming Buy and 3 Other Hot Stocks Mar 27
- Chelsea Therapeutics (CHTP) Higher Following Blog Post Street Insider Mar 27
- Chelsea Therapeutics: A Shoe-In For FDA Approval, Shares Could Double From Here Mar 26
CHTP Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Chelsea Therapeutics International is down 5.53% over the last year vs S&P 500 Total Return up 31.68%, Achillion Pharmaceuticals up 19.54%, and Merrimack Pharmaceuticals down 24.38%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Pro Ratings for CHTP
Pro Report PDF for CHTP
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download CHTP Pro Report PDF
Pro Strategies Featuring CHTP
Did Chelsea Therapeutics International make it into our Pro Portfolio Strategies?